首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1593475

細胞計數市場規模、佔有率、成長分析、按產品、按應用、按最終用戶、按地區 - 行業預測，2024-2031 年

Cell Counting Market Size, Share, Growth Analysis, By Product, By Application, By End User, By Region - Industry Forecast 2024-2031

出版日期: 2024年11月10日 | 出版商:

SkyQuest | 英文 189 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球細胞計數市場規模為98億美元，從2023年的104.7億美元成長到2031年的177.2億美元，年複合成長率預計為6.80%。

由於細胞生物學、癌症研究和免疫學等領域的研究重點不斷增加，細胞計數市場正在經歷強勁成長。促成這一市場擴張的主要因素是個人化醫療需求的不斷成長、慢性疾病患者數量的快速增加以及細胞計數技術的持續進步。然而，技術複雜性和缺乏操作這些技術的熟練人員等挑戰正在阻礙市場成長。儘管有這些限制，但隨著創新技術的引入和細胞療法的重要性日益增加，產業不斷發展，前景仍然樂觀。此外，數位技術的整合正在改變細胞計數方法並進一步增加市場潛力。因此，細胞計數市場預計將保持上升趨勢，滿足醫學研究和診斷領域的多樣化應用，並最終提高醫療保健結果的品質。

市場概況
消耗品
- 培養基血清試劑
- 檢測試劑套件
- 微孔盤
- 配件
- 其他消耗品
裝置
- 光強度
- 單模式讀卡機
- 多模式讀卡器
- 流式細胞儀
- 血液分析儀
- 全自動分析儀
- 半自動血液分析儀
- 細胞計數器
- 自動細胞計數儀
- 血球計數器/手動細胞計數器
- 顯微鏡

細胞計數市場：依應用分類

市場概況
研究用途
- 癌症研究
- 免疫學研究
- 神經學調查
- 幹細胞研究
- 其他研究用途
醫療用途
- 非侵入性產前診斷
- 體外受精
- 循環性腫瘤細胞的檢測
工業用途

細胞計數市場：依最終用戶分類

市場概況
調查機構
醫院和診斷實驗室
製藥和生物技術公司以及合約研究組織 (CROS)
其他最終用戶

細胞計數市場：按地區

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 阿拉伯聯合大公國國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Danaher Corporation（US）
Thermo Fisher Scientific（US）
Becton, Dickinson and Company（US）
Merck KGaA（Germany）
Bio-Rad Laboratories Inc.（US）
Abbott Laboratories（US）
PerkinElmer, Inc.（US）
Agilent Technologies, Inc.（US）
Corning（US）
Tecan（Switzerland）
Boule Diagnostics AB（Sweden）
Olympus Corporation（Japan）
Horiba（Japan）
Sysmex Corporation（Japan）
Siemens Healthineers AG（Germany）
F. Hoffmann-La Roche AG（Switzerland）
Luminex Corporation（US）
Nexcelom Bioscience LLC（US）
Tip Biosystems（Singapore）
Logos Biosystems, Inc.（South Korea）

簡介目錄

Product Code: SQMIG35H2305

Global Cell Counting Market size was valued at USD 9.8 billion in 2022 and is poised to grow from USD 10.47 billion in 2023 to USD 17.72 billion by 2031, growing at a CAGR of 6.80% during the forecast period (2024-2031).

The cell counting market is witnessing robust growth driven by the increasing focus on research in areas such as cell biology, cancer research, and immunology. This market expansion is primarily fueled by the rising demand for personalized medicine, the surge in chronic disease cases, and ongoing advancements in cell counting technologies. However, challenges such as technical complexities and a shortage of skilled personnel to operate these technologies present hurdles to market growth. Despite these constraints, the outlook remains positive as the industry evolves with the introduction of innovative technologies and the rising significance of cell-based therapies. Additionally, the integration of digital technologies is transforming cell counting methods, further boosting market potential. As a result, the cell counting market is expected to continue its upward trajectory, accommodating a diverse range of applications in medical research and diagnostics, and ultimately enhancing the quality of healthcare outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Counting market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Counting Market Segmental Analysis

Global Cell Counting Market is segmented by Product, Application, End User, and region. Based on Product, the market is segmented into Consumables, and Instruments. Based on Application, the market is segmented into Research Applications, Medical Applications, and Industrial Applications. Based on End User, the market is segmented into Research Institutes, Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies and Contract Research Organizations (CROS), and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Cell Counting Market

The Global Cell Counting market is significantly driven by major advancements in technology, including the development of superior automated cell counters, high-tech flow cytometers, and enhanced imaging systems. These innovations enhance the reliability and efficiency of cell counting processes, thereby increasing demand across various sectors such as clinical diagnostics and research. The improved accuracy and speed of these advanced systems not only facilitate precise cell analysis but also contribute to better clinical outcomes and research efficacy. As healthcare and life sciences continue to emphasize the importance of accurate diagnostics and data-driven research, the demand for advanced cell counting solutions is poised for robust growth.

Restraints in the Global Cell Counting Market

One significant market restraint affecting the Global Cell Counting market is the limited reimbursement options available for certain cell counting systems in various regions. This inadequacy can negatively influence the financial feasibility of adopting advanced technologies, thereby detracting from potential demand. The financial burden on researchers and healthcare providers arising from insufficient reimbursement may deter them from exploring and investing in novel cell counting solutions, ultimately impeding innovation and growth in the sector. As a result, the hesitance to embrace cutting-edge cell counting technologies due to reimbursement issues poses a considerable challenge to market expansion and development.

Market Trends of the Global Cell Counting Market

The Global Cell Counting Market is witnessing a notable trend characterized by a heightened emphasis on assessing cell functionality and viability, moving beyond traditional counting methods. Researchers and clinicians are increasingly recognizing the importance of evaluating cell activity and health, particularly in applications such as drug development, cancer research, and regenerative medicine. This demand is driving innovation in technologies that not only quantify cells but also provide comprehensive insights into cellular behavior. As a result, novel solutions are being developed to enhance the accuracy and efficiency of cell viability assays, thereby expanding the scope of applications and fostering growth within the market.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Regulatory Analysis
Value Chain Analysis
Case Study Analysis

Cell Counting Market by Product

Market Overview
Consumables
- Media, Sera, And Reagents
- Assay Kits
- Microplates
- Accessories
- Other Consumables
Instruments
- Spectrophotometers
- Single-Mode Readers
- Multi-Mode Readers
- Flow Cytometers
- Hematology Analyzers
- Fully Automated Analyzers
- Semi-Automated Hematology Analyzers
- Cell Counters
- Automated Cell Counters
- Hemocytometers/Manual Cell Counters
- Microscopes

Cell Counting Market by Application

Market Overview
Research Applications
- Cancer Research
- Immunology Research
- Neurology Research
- Stem Cell Research
- Other Research Applications
Medical Applications
- Noninvasive Prenatal Diagnosis
- In Vitro Fertilization
- Circulating Tumor Cell Detection
Industrial Applications

Cell Counting Market by End User

Market Overview
Research Institutes
Hospitals & Diagnostic Laboratories
Pharmaceutical & Biotechnology Companies and Contract Research Organizations (CROS)
Other End Users

Cell Counting Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Corning (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tecan (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boule Diagnostics AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Horiba (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Luminex Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nexcelom Bioscience LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tip Biosystems (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Logos Biosystems, Inc. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments